| 1426P The utility of the prognostic index for practicing the continuum of care in advanced gastric cancer: The suitability assessment and modification of the JCOG prognostic … K Shimozaki, I Nakayama, D Takahari, H Osumi, D Kamiimabeppu, ... Annals of Oncology 32, S1067-S1068, 2021 | | 2021 |
| 1537P A phase I study of pevonedistat plus capeOX in patients with advanced gastric cancer refractory to platinum (NCCH-1811) D Takahari, H Shoji, A Ooki, H Hirano, NT Okita, K Nagashima, J Adachi, ... Annals of Oncology 34, S864, 2023 | | 2023 |
| 1554P Clinical Impact of ERBB2 copy number and tumor mutation burden (TMB) in patients with HER2-positive advanced gastric cancer treated by nivolumab (N-mab) plus trastuzumab … H Shoji, T Wakatsuki, D Takahari, N Yamamoto, A Ooki, K Chin, ... Annals of Oncology 34, S871, 2023 | | 2023 |
| 1561P APC mutation (mt.), MYC, and GATA6 amplifications (amp.) were associated with worse survival in HER2-positive advanced gastric cancer patients treated with S-1 … T Wakatsuki, D Takahari, N Yamamoto, A Ooki, K Chin, N Kurihara, ... Annals of Oncology 34, S873-S874, 2023 | | 2023 |
| 1566P Clinical relevance of circulating tumor DNA in HER2-positive advanced gastric cancer: Results from phase Ib trial of HER2 and PD-1 dual targeted therapy (Ni-High) H Osumi, T Wakatsuki, D Takahari, A Ooki, K Chin, H Shoji, M Ogura, ... Annals of Oncology 34, S875-S876, 2023 | | 2023 |
| 158P A phase II study of trastuzumab with S-1 plus oxaliplatin for HER2-positive advanced gastric cancer (HIGHSOX study) A Takashima, K Chin, K Minashi, S Kadowaki, T Nishina, N Izawa, ... Annals of Oncology 31, S1301, 2020 | | 2020 |
| 164P Does patient selection according to RAS/PIK3CA/BRAF mutational status enrich the efficacy of adjuvant chemotherapy for Stage IV CRC after R0 resection? I Nakayama, E Shinozaki, T Azuma, T Wakatsuki, M Ogura, T Ichimura, ... Annals of Oncology 26, ix42, 2015 | | 2015 |
| 6096 Frequency of KRAS/BRAF mutations as predictive markers for Cetuximab in Japanese colorectal cancer patients T Yokota, N Shibata, T Ura, D Takahari, K Shitara, K Muro, Y Yatabe EJC Supplements 2 (7), 351, 2009 | | 2009 |
| 6100 POSTER Prolonged Survival of Patients With Metastatic Colorectal Cancer Who Underwent First-line Oxaliplatin Based Chemotherapy With the Introduction of Molecular … K Shitara, K Matsuo, C Kondo, D Takahari, T Ura, K Muro European Journal of Cancer, S421-S422, 2011 | | 2011 |
| 6121 POSTER Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC) D Takahari, H Takiuchi, K Muro, A Tsuji, Y Hamamoto, T Yoshino, ... European Journal of Cancer, S428-S429, 2011 | 2 | 2011 |
| 6513 POSTER Reporting Patient Characteristics and Stratification Factors in Randomized Trials of Systemic Chemotherapy for Advanced Gastric Cancer K Shitara, J Ikeda, C Kondo, D Takahari, K Muro, K Matsuo European Journal of Cancer, S446, 2011 | | 2011 |
| 6529 POSTER Lymph Node Size Is a Strong Prognostic Factor for Patients With Esophageal Cancer Treated by Chemoradiotherapy M Nomura, K Shitara, T Kodaira, A Mizota, C Kondoh, T Yokota, ... European Journal of Cancer, S450-S451, 2011 | | 2011 |
| A case of advanced gastric cancer with poor performance status which improved by chemotherapy K Shitara, D Takahari Case Reports in Oncology 3 (2), 262-267, 2010 | 3 | 2010 |
| A case of heavily pretreated rectal cancer with disseminated intravascular coagulation that improved following reintroduction of FOLFOX plus bevacizumab A Mizota, K Shitara, C Kondo, M Nomura, T Yokota, D Takahari, T Ura, ... International journal of clinical oncology 16, 766-769, 2011 | 15 | 2011 |
| A feasibility study of outpatient chemotherapy with S-1+ cisplatin in patients with advanced gastric cancer S Okazaki, TE Nakajima, J Hashimoto, S Yamamoto, D Takahari, K Kato, ... Gastric Cancer 16, 41-47, 2013 | 11 | 2013 |
| A feasibility study of TAS-118 plus oxaliplatin as perioperative chemotherapy for locally advanced gastric cancer A Takashima, D Takahari, N Ishizuka, H Katai, TE Nakajima, M Ohashi, ... Annals of Oncology 28, v264, 2017 | | 2017 |
| A multi-institutional observational study evaluating the incidence and the clinicopathological characteristics of NeoRAS wild-type metastatic colorectal cancer. Y Yoshinami, H Osumi, A Takashima, R Sawada, K Ouchi, T Wakatsuki, ... Journal of Clinical Oncology 41 (4_suppl), 206-206, 2023 | | 2023 |
| A multi-institutional observational study evaluating the incidence and the clinicopathological characteristics of NeoRAS wild-type metastatic colorectal cancer H Osumi, A Takashima, A Ooki, Y Yoshinari, T Wakatsuki, H Hirano, ... Translational Oncology 35, 101718, 2023 | 3 | 2023 |
| A multicenter phase II study of TAS-114 in combination with S-1 in patients with pre-treated advanced gastric cancer (EPOC1604) D Takahari, A Kawazoe, Y Nakamura, H Tamura, M Fukutani, N Hirano, ... Annals of Oncology 30, v303-v304, 2019 | | 2019 |
| A multicenter phase II study of TAS-114 in combination with S-1 in patients with pre-treated advanced gastric cancer (EPOC1604): Interim analysis in the first stage A Kawazoe, D Takahari, Y Nakamura, M Suzuki, H Tamura, M Fukutani, ... Annals of Oncology 29, v19-v20, 2018 | | 2018 |
